DENTSPLY SIRONA (NASDAQ:XRAY) Issues Earnings Results, Beats Expectations By $0.02 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) released its quarterly earnings data on Thursday. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02, Briefing.com reports. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company’s revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 EPS. DENTSPLY SIRONA updated its FY 2024 guidance to 1.820-1.860 EPS and its FY24 guidance to $1.82-$1.86 EPS.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded up $0.60 during trading on Friday, reaching $17.86. The company’s stock had a trading volume of 9,385,798 shares, compared to its average volume of 3,107,804. The firm has a 50 day moving average of $24.82 and a 200-day moving average of $25.98. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The firm has a market cap of $3.62 billion, a price-to-earnings ratio of -8.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.02. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research reports. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday. Needham & Company LLC dropped their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday. Finally, StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Wednesday. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $29.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.